1. Home
  2. PHGE vs STIM Comparison

PHGE vs STIM Comparison

Compare PHGE & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • STIM
  • Stock Information
  • Founded
  • PHGE 2015
  • STIM 2003
  • Country
  • PHGE Israel
  • STIM United States
  • Employees
  • PHGE N/A
  • STIM N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • STIM Medical/Dental Instruments
  • Sector
  • PHGE Health Care
  • STIM Health Care
  • Exchange
  • PHGE Nasdaq
  • STIM Nasdaq
  • Market Cap
  • PHGE 26.5M
  • STIM 29.4M
  • IPO Year
  • PHGE N/A
  • STIM 2018
  • Fundamental
  • Price
  • PHGE $0.75
  • STIM $0.65
  • Analyst Decision
  • PHGE Strong Buy
  • STIM Buy
  • Analyst Count
  • PHGE 2
  • STIM 4
  • Target Price
  • PHGE $22.50
  • STIM $4.67
  • AVG Volume (30 Days)
  • PHGE 151.9K
  • STIM 720.8K
  • Earning Date
  • PHGE 11-14-2024
  • STIM 11-12-2024
  • Dividend Yield
  • PHGE N/A
  • STIM N/A
  • EPS Growth
  • PHGE N/A
  • STIM N/A
  • EPS
  • PHGE N/A
  • STIM N/A
  • Revenue
  • PHGE N/A
  • STIM $72,711,000.00
  • Revenue This Year
  • PHGE N/A
  • STIM $11.40
  • Revenue Next Year
  • PHGE N/A
  • STIM $12.09
  • P/E Ratio
  • PHGE N/A
  • STIM N/A
  • Revenue Growth
  • PHGE N/A
  • STIM 5.03
  • 52 Week Low
  • PHGE $0.62
  • STIM $0.52
  • 52 Week High
  • PHGE $8.55
  • STIM $5.07
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 36.37
  • STIM 30.53
  • Support Level
  • PHGE $0.67
  • STIM $0.52
  • Resistance Level
  • PHGE $0.81
  • STIM $1.20
  • Average True Range (ATR)
  • PHGE 0.09
  • STIM 0.10
  • MACD
  • PHGE 0.00
  • STIM -0.06
  • Stochastic Oscillator
  • PHGE 44.00
  • STIM 11.96

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: